Revival of physostigmine: a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients
Background: Physostigmine, commonly used as an antidote in anticholinergic poisoning, is reported to have additional pharmacological effects, such as activation of the cholinergic anti-inflammatory pathway in sepsis models. Due to the narrow therapeutic range of physostigmine and its metabolite eser...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July 2015
|
| In: |
Clinical chemistry and laboratory medicine
Year: 2015, Jahrgang: 53, Heft: 8, Pages: 1259-1264 |
| ISSN: | 1437-4331 |
| DOI: | 10.1515/cclm-2014-0834 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1515/cclm-2014-0834 Verlag, Volltext: https://www.degruyterbrill.com/view/j/cclm.2015.53.issue-8/cclm-2014-0834/cclm-2014-0834.xml 
|
| Verfasserangaben: | Nadine Pinder, Johannes B. Zimmermann, Stefan Hofer, Thorsten Brenner, Markus A. Weigand, Ute Gubbe, Torsten Hoppe-Tichy, Stefanie Swoboda |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1556279272 | ||
| 003 | DE-627 | ||
| 005 | 20250530010143.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170404s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/cclm-2014-0834 |2 doi | |
| 035 | |a (DE-627)1556279272 | ||
| 035 | |a (DE-576)486279278 | ||
| 035 | |a (DE-599)BSZ486279278 | ||
| 035 | |a (OCoLC)1340972636 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pinder, Nadine |d 1985- |e VerfasserIn |0 (DE-588)112920605X |0 (DE-627)88385855X |0 (DE-576)486279235 |4 aut | |
| 245 | 1 | 0 | |a Revival of physostigmine |b a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients |c Nadine Pinder, Johannes B. Zimmermann, Stefan Hofer, Thorsten Brenner, Markus A. Weigand, Ute Gubbe, Torsten Hoppe-Tichy, Stefanie Swoboda |
| 264 | 1 | |c July 2015 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.04.2017 | ||
| 520 | |a Background: Physostigmine, commonly used as an antidote in anticholinergic poisoning, is reported to have additional pharmacological effects, such as activation of the cholinergic anti-inflammatory pathway in sepsis models. Due to the narrow therapeutic range of physostigmine and its metabolite eseroline, however, the plasma concentrations of these substances need to be determined so as to understand their effect and ensure safety in the treatment of septic patients. | ||
| 700 | 1 | |a Zimmermann, Johannes B. |d 1978- |e VerfasserIn |0 (DE-588)1052919960 |0 (DE-627)789310368 |0 (DE-576)408663421 |4 aut | |
| 700 | 1 | |a Hofer, Stefan |d 1971- |e VerfasserIn |0 (DE-588)122418506 |0 (DE-627)70590072X |0 (DE-576)187683867 |4 aut | |
| 700 | 1 | |a Brenner, Thorsten |d 1978- |e VerfasserIn |0 (DE-588)130125709 |0 (DE-627)491713363 |0 (DE-576)189360607 |4 aut | |
| 700 | 1 | |a Weigand, Markus A. |d 1967- |e VerfasserIn |0 (DE-588)1064970435 |0 (DE-627)815375239 |0 (DE-576)424658666 |4 aut | |
| 700 | 1 | |a Gubbe, Ute |e VerfasserIn |0 (DE-588)1129206114 |0 (DE-627)883858703 |0 (DE-576)486279189 |4 aut | |
| 700 | 1 | |a Hoppe-Tichy, Torsten |e VerfasserIn |0 (DE-588)1095801376 |0 (DE-627)856418919 |0 (DE-576)467814597 |4 aut | |
| 700 | 1 | |a Swoboda, Stefanie |d 1974- |e VerfasserIn |0 (DE-588)128401591 |0 (DE-627)372642896 |0 (DE-576)297124838 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d Berlin [u.a.] : De Gruyter, 1998 |g 53(2015), 8, Seite 1259-1264 |h Online-Ressource |w (DE-627)302923187 |w (DE-600)1492732-9 |w (DE-576)088704882 |x 1437-4331 |7 nnas |a Revival of physostigmine a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients |
| 773 | 1 | 8 | |g volume:53 |g year:2015 |g number:8 |g pages:1259-1264 |g extent:6 |a Revival of physostigmine a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1515/cclm-2014-0834 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.degruyterbrill.com/view/j/cclm.2015.53.issue-8/cclm-2014-0834/cclm-2014-0834.xml |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170404 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 128401591 |a Swoboda, Stefanie |m 128401591:Swoboda, Stefanie |d 910000 |e 910000PS128401591 |k 0/910000/ |p 8 |y j | ||
| 998 | |g 1095801376 |a Hoppe-Tichy, Torsten |m 1095801376:Hoppe-Tichy, Torsten |d 910000 |e 910000PH1095801376 |k 0/910000/ |p 7 | ||
| 998 | |g 1129206114 |a Gubbe, Ute |m 1129206114:Gubbe, Ute |d 910000 |e 910000PG1129206114 |k 0/910000/ |p 6 | ||
| 998 | |g 1064970435 |a Weigand, Markus A. |m 1064970435:Weigand, Markus A. |d 910000 |d 910300 |e 910000PW1064970435 |e 910300PW1064970435 |k 0/910000/ |k 1/910000/910300/ |p 5 | ||
| 998 | |g 130125709 |a Brenner, Thorsten |m 130125709:Brenner, Thorsten |d 910000 |d 910300 |e 910000PB130125709 |e 910300PB130125709 |k 0/910000/ |k 1/910000/910300/ |p 4 | ||
| 998 | |g 122418506 |a Hofer, Stefan |m 122418506:Hofer, Stefan |d 910000 |d 910300 |e 910000PH122418506 |e 910300PH122418506 |k 0/910000/ |k 1/910000/910300/ |p 3 | ||
| 998 | |g 1052919960 |a Zimmermann, Johannes B. |m 1052919960:Zimmermann, Johannes B. |d 910000 |d 910300 |e 910000PZ1052919960 |e 910300PZ1052919960 |k 0/910000/ |k 1/910000/910300/ |p 2 | ||
| 998 | |g 112920605X |a Pinder, Nadine |m 112920605X:Pinder, Nadine |d 910000 |e 910000PP112920605X |k 0/910000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1556279272 |e 2963935471 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Pinder","given":"Nadine","display":"Pinder, Nadine","role":"aut"},{"role":"aut","display":"Zimmermann, Johannes B.","given":"Johannes B.","family":"Zimmermann"},{"family":"Hofer","given":"Stefan","display":"Hofer, Stefan","role":"aut"},{"display":"Brenner, Thorsten","given":"Thorsten","family":"Brenner","role":"aut"},{"family":"Weigand","given":"Markus A.","display":"Weigand, Markus A.","role":"aut"},{"display":"Gubbe, Ute","given":"Ute","family":"Gubbe","role":"aut"},{"family":"Hoppe-Tichy","display":"Hoppe-Tichy, Torsten","given":"Torsten","role":"aut"},{"role":"aut","given":"Stefanie","display":"Swoboda, Stefanie","family":"Swoboda"}],"recId":"1556279272","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"July 2015"}],"name":{"displayForm":["Nadine Pinder, Johannes B. Zimmermann, Stefan Hofer, Thorsten Brenner, Markus A. Weigand, Ute Gubbe, Torsten Hoppe-Tichy, Stefanie Swoboda"]},"language":["eng"],"title":[{"title":"Revival of physostigmine","subtitle":"a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients","title_sort":"Revival of physostigmine"}],"physDesc":[{"extent":"6 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1515/cclm-2014-0834"],"eki":["1556279272"]},"relHost":[{"title":[{"title":"Clinical chemistry and laboratory medicine","title_sort":"Clinical chemistry and laboratory medicine"}],"name":{"displayForm":["publ. in association with the International Federation of Clinical Chemistry and Laboratory Medicine and the Forum of the European Societies of Clinical Chemistry"]},"origin":[{"dateIssuedKey":"1998","publisherPlace":"Berlin [u.a.]","publisher":"De Gruyter","dateIssuedDisp":"1998-"}],"note":["Gesehen am 22.6.2022"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"8","extent":"6","pages":"1259-1264","year":"2015","volume":"53","text":"53(2015), 8, Seite 1259-1264"},"id":{"zdb":["1492732-9"],"issn":["1437-4331"],"doi":["10.1515/cclm"],"eki":["302923187"]},"language":["eng"],"titleAlt":[{"title":"CCLM"}],"disp":"Revival of physostigmine a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patientsClinical chemistry and laboratory medicine","recId":"302923187","type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["36.1998-"]}],"note":["Gesehen am 04.04.2017"]} | ||
| SRT | |a PINDERNADIREVIVALOFP2015 | ||